【offer information】Okayama University Medical Research Updates （OU-MRU）Vol.84「Friend to Foe—When Harmless Bacteria Turn Toxic」

Source: Okayama University (JAPAN), Public Relations Division
For immediate release: 27 November 2020
Okayama University research: Friend to Foe—When Harmless Bacteria Turn Toxic

(Okayama, 27 November) In a study recently published in PLoS Pathogens, researchers at Okayama University reveal novel mutations which transform bacteria into infectious bugs that are resistant to antibiotics.

Not all bacteria are naturally infectious. Several strains of innocuous bacteria turn infectious over their lifespan. However, the mechanisms by which such bacteria acquire pathogenic properties (known as virulence in microbiology terms) are still a mystery. Now, a research team led by Professor KAITO Chikara from Okayama University has identified specific gene mutations which drive this deadly switch in the microorganisms.

The researchers employed a non-pathogenic strain of Escherichia coli, bacteria commonly used in the laboratory, and exposed them to mutation-inducing processes. The bacteria were subsequently injected into silkworms. After multiple rounds of mutagen exposure, the E.coli started swiftly killing the worms, turning 500 times more lethal at a certain point. A closer look at the DNA of this dangerous strain revealed mutations in a protein known as the lipopolysaccharide (LPS) transporter. The LPS transporter resides on the bacterial membrane and funnels LPS, a bacterial toxin, from within the cell onto its surface. To understand how these mutations were linked to bacterial toxicity, the mutant E.coli were treated with host antimicrobial peptides or antibiotics. These antimicrobial molecules, however, did not hamper the growth of the mutant bacteria suggesting that the mutants had developed resistance against host immune response and antibiotics.

Bacteria store an arsenal of chemicals on their surface within small vesicles. The mutant E.coli had an abundance of such vesicles which were also rich in LPS. It thus seemed that the bugs had developed a clever mechanism to expel toxins and chemicals out of the cell. The team then analysed the LPS transporter to investigate whether its mutations played a role in this regard. Indeed, the structure of the LPS transporter was found altered in the mutant strains. A plug which keeps the channel of the transporter closed, appeared defective. Lastly, to see whether similar mutations in the LPS transporter occur naturally, the team examined bacterial samples taken from patients. As expected, these samples contained similar mutants of E.coli which were also resistant to antimicrobials. Mutations in the LPS transporter were thus conferring bacteria with crafty mechanisms to stay alive and infect host cells.

“These findings suggest that non-pathogenic bacteria can gain virulence traits by changing the functions of essential genes, and provide new insight to bacterial evolution in a host environment,” conclude the researchers. Information on such toxic mutations in bacteria are vital for diagnosing infections and developing appropriate antibacterial drugs.

Background

Virulence – A microorganism's ability to infect a host cell is known as virulence. Organisms have varying mechanisms of virulence known as virulence factors. Common virulence factors driving bacterial toxicity are chemicals that help bacteria invade and adhere to host cells or poisons that damage host cells. A thorough understanding of these factors is key to developing strategies for combatting bacterial toxicity.

Lipopolysaccharide (LPS) – LPS is a chemical that forms a major component of the outer membrane of bacteria. Once synthesized within the bacterial cell, it is pushed out through a channel known as the LPS transporter to subsequently reside within the outer membrane. LPS protects the bacterial membrane from foreign attacks and induces responses such as inflammation, fever, and septic shock when bacteria infect hosts. Thus, LPS is a crucial component of the bacterial defense system.

Reference

Chikara Kaito, Hirono Yoshikai, Ai Wakamatsu, Atsushi Miyashita, Yasuhiko Matsumoto, Tomoko Fujiyuki, Masaru Kato, Yoshitoshi Ogura, Tetsuya Hayashi, Takao Isogai, Kazuhisa Sekimizu. Non-pathogenic Escherichia coli acquires virulence by mutating a growth-essential LPS transporter. PLoS Pathogens, 2020 Apr; 16(4): e1008469.

DOI : 10.1371/journal.ppat.1008469


Correspondence to
Professor KAITO Chikara, Ph.D.
Division of Immunobiology,
Graduate School of Medicine, Dentistry and Pharmaceutical
Sciences, Okayama University, 1-1-1, Tsushima-naka, Kita-ku,
Okayama 700-8530, Japan
e-mail : ckaito(a)okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.
http://www.pharm.okayama-u.ac.jp/lab/bunsei/

Further information
Okayama University
1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan
Public Relations Division
E-mail: www-adm(a)adm.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.

Website: //www.okayama-u.ac.jp/index_e.html
Okayama Univ. e-Bulletin: //www.okayama-u.ac.jp/user/kouhou/ebulletin/
We love OKAYAMA UNIVERSITY: https://www.youtube.com/watch?v=7cXlttQIk3E
Okayama University Image Movie（2020）
https://www.youtube.com/watch?v=vQxeL0ztSLA

Okayama University Medical Research Updates （OU-MRU）
The whole volume : OU-MRU (1- )
Vol.1：Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testing
Vol.2：Ensuring a cool recovery from cardiac arrest
Vol.3：Organ regeneration research leaps forward
Vol.4：Cardiac mechanosensitive integrator
Vol.5：Cell injections get to the heart of congenital defects
Vol.6：Fourth key molecule identified in bone development
Vol.7：Anticancer virus solution provides an alternative to surgery
Vol.8：Light-responsive dye stimulates sight in genetically blind patients
Vol.9：Diabetes drug helps towards immunity against cancer
Vol.10：Enzyme-inhibitors treat drug-resistant epilepsy
Vol.11：Compound-protein combination shows promise for arthritis treatment
Vol.12：Molecular features of the circadian clock system in fruit flies
Vol.13：Peptide directs artificial tissue growth
Vol.14：Simplified boron compound may treat brain tumours
Vol.15：Metamaterial absorbers for infrared inspection technologies
Vol.16：Epigenetics research traces how crickets restore lost limbs
Vol.17：Cell research shows pathway for suppressing hepatitis B virus
Vol.18：Therapeutic protein targets liver disease
Vol.19：Study links signalling protein to osteoarthritis
Vol.20：Lack of enzyme promotes fatty liver disease in thin patients
Vol.21：Combined gene transduction and light therapy targets gastric cancer
Vol.22：Medical supportive device for hemodialysis catheter puncture
Vol.23：Development of low cost oral inactivated vaccines for dysentery
Vol.24：Sticky molecules to tackle obesity and diabetes
Vol.25：Self-administered aroma foot massage may reduce symptoms of anxiety
Vol.26：Protein for preventing heart failure
Vol.27：Keeping cells in shape to fight sepsis
Vol.28：Viral-based therapy for bone cancer
Vol.29：Photoreactive compound allows protein synthesis control with light
Vol.30：Cancer stem cells’ role in tumor growth revealed
Vol.31：Prevention of RNA virus replication
Vol.32：Enzyme target for slowing bladder cancer invasion
Vol.33：Attacking tumors from the inside
Vol.34：Novel mouse model for studying pancreatic cancer
Vol.35：Potential cause of Lafora disease revealed
Vol.36：Overloading of protein localization triggers cellular defects
Vol.37：Protein dosage compensation mechanism unravelled
Vol.38：Bioengineered tooth restoration in a large mammal
Vol.39：Successful test of retinal prosthesis implanted in rats
Vol.40：Antibodies prolong seizure latency in epileptic mice
Vol.41：Inorganic biomaterials for soft-tissue adhesion
Vol.42：Potential drug for treating chronic pain with few side effects
Vol.43：Potential origin of cancer-associated cells revealed
Vol.44：Protection from plant extracts
Vol.45：Link between biological-clock disturbance and brain dysfunction uncovered
Vol.46：New method for suppressing lung cancer oncogene
Vol.47：Candidate genes for eye misalignment identified
Vol.48：Nanotechnology-based approach to cancer virotherapy
Vol.49：Cell membrane as material for bone formation
Vol.50：Iron removal as a potential cancer therapy
Vol.51：Potential of 3D nanoenvironments for experimental cancer
Vol.52：A protein found on the surface of cells plays an integral role in tumor growth and sustenance
Vol.53：Successful implantation and testing of retinal prosthesis in monkey eyes with retinal degeneration
Vol.54：Measuring ion concentration in solutions for clinical and environmental research
Vol.55：Diabetic kidney disease: new biomarkers improve the prediction of the renal prognosis
Vol.56：New device for assisting accurate hemodialysis catheter placement
Vol.57：Possible link between excess chewing muscle activity and dental disease
Vol.58：Insights into mechanisms governing the resistance to the anti-cancer medication cetuximab
Vol.59：Role of commensal flora in periodontal immune response investigated
Vol.60：Role of commensal microbiota in bone remodeling
Vol.61：Mechanical stress affects normal bone development
Vol.62：3D tissue model offers insights into treating pancreatic cancer
Vol.63：Promising biomarker for vascular disease relapse revealed
Vol.64：Inflammation in the brain enhances the side-effects of hypnotic medication
Vol.65：Game changer: How do bacteria play Tag ?
Vol.66：Is too much protein a bad thing?
Vol.67：Technology to rapidly detect cancer markers for cancer diagnosis
Vol.68：Improving the diagnosis of pancreatic cancer
Vol.69：Early gastric cancer endoscopic diagnosis system using artificial intelligence
Vol.70：Prosthetics for Retinal Stimulation
Vol.71：The nervous system can contribute to breast cancer progression
Vol.72：Synthetic compound provides fast screening for potential drugs
Vol.73：Primary intraocular lymphoma does not always spread to the central nervous system 

Vol.74：Rising from the ashes—dead brain cells can be regenerated after traumatic injury
Vol.75：More than just daily supplements — herbal medicines can treat stomach disorders
Vol.76：The molecular pathogenesis of muscular dystrophy-associated cardiomyopathy
Vol.77：Green leafy vegetables contain a compound which can fight cancer cells
Vol.78：Disrupting blood supply to tumors as a new strategy to treat oral cancer
Vol.79：Novel blood-based markers to detect Alzheimer’s disease

Vol.80：A novel 3D cell culture model sheds light on the mechanisms driving fibrosis in pancreatic cancer

Vol.81：Innovative method for determining carcinogenicity of chemicals using iPS cells

Vol.82：Making memories — the workings of a neuron revealed

Vol.83：Skipping a beat — a novel method to study heart attacks

 

Top. Mutant bacteria (LptD G580S and LptE T95I) were resistant to common antimicrobial drugs and survived in their presence compared to the nonmutated (LptD WT and LptE WT) strains.

Bottom. A graphical representation of the structural alteration in the LPS transporter induced by the mutations resulting in a rearrangement of the plug (L4) that keeps the channel closed.

 

Professor KAITO Chikara

Okayama University supports the Sustainable Development Goals

 

https://www.okayama-u.ac.jp/eng/research_highlights/index_id119.html